PORTA, FEDERICA
PORTA, FEDERICA
Dipartimento di Scienze Farmaceutiche
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity
2019 A. Gelain, M. Mori, F. Meneghetti, F. Porta, L. Basile, G. Marverti, A. Asai, M. Hyeraci, A.N. García-Argáez, L.D. Via, S. Guccione, S. Villa
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL ANTIPROLIFERATIVE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS
2017 F. Porta
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity
2017 F. Porta, A. Gelain, D. Barlocco, N. Ferri, S. Marchiano', V. Cappello, L. Basile, S. Guccione, F. Meneghetti, S. Villa
New 1,2,5-oxadiazole Pt(II)complex endowed with STAT3 inhibitory properties as promising anticancer agent
2017 A. Gelain, S. Villa, F. Meneghetti, F. Porta, G. Facchetti, N. Ferri, A. Asai, V. Gandin, C. Marzano, I. Rimoldi
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest
2017 E. Gabriele, F. Porta, G. Facchetti, C. Galli, A. Gelain, F. Meneghetti, I. Rimoldi, S. Romeo, S. Villa, C. Ricci, N. Ferri, A. Asai, D. Barlocco, A. Sparatore
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties
2017 F. Porta, G. Facchetti, N. Ferri, A. Gelain, F. Meneghetti, S. Villa, D. Barlocco, D. Masciocchi, A. Asai, N. Miyoshi, S. Marchianò, B. Kwon, Y. Jin, V. Gandin, C. Marzano, I. Rimoldi
An oxadiazole Pt(II) complex with promising in vivo antitumor activity
2016 F. Porta, G. Facchetti, S. Villa, A. Gelain, F. Meneghetti, D. Barlocco, N. Ferri, C. Marzano, V. Gandin, A. Asai, I. Rimoldi
Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach
2016 G. Poli, A. Gelain, F. Porta, A. Asai, A. Martinelli, T. Tuccinardi
New Platinum(II) complexes in STAT3 inhibition: a promising tool for anticancer therapy
2015 I. Rimoldi, F. Porta, S. Villa, A. Gelain, F. Meneghetti, D. Barlocco, N. Ferri, A. Asai, G. Facchetti
Mycobacterium tuberculosis Low Molecular Weight Phosphatases (MPtpA and MPtpB) : from Biological Insight to Inhibitors
2015 L. Fanzani, F. Porta, F. Meneghetti, S. Villa, A. Gelain, A.P. Lucarelli, E. Parisini
STAT3 direct inhibitors: from MD77 to AC33
2015 F. Porta, S. Villa, A. Gelain, D. Barlocco, I. Rimoldi, G. Facchetti, N. Ferri, A. Asai
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy
2015 G. Facchetti, F. Porta, S. Villa, A. Gelain, F. Meneghetti, D. Barlocco, N. Ferri, A. Asai, I. Rimoldi
Development of novel substituted naphthyl amino benzoic acid derivatives as CDC25 phosphatase inhibitors: design, synthesis and biological evaluation
2015 C. Cerchia, F. Porta, A. Capasso, C. Di Giovanni, S. Sarno, A. Gelain, S. Villa, M.R. Ruocco, E. De Vendittis, A. Lavecchiaa
Methanethiosulfonate derivatives as ligands of STAT3-SH2 domain
2014 E. Gabriele, A. Barteselli, V. Moiana, F. Porta, A. Gelain, A. Asai, A. Sparatore
Sviluppo di MD77: nuovi derivati eterociclici inibenti STAT3
2014 A. Gelain, F. Porta, S. Dell’Orto, S. Villa, D. Masciocchi, D. Barlocco, F. Meneghetti, N. Ferri, G. Poli, T. Tuccinardi, B.M. Kwon, A. Asai
Identification of a novel STAT3 inhibitor structurally related to the oxadiazole derivative MD77
2013 D. Masciocchi, S. Villa, F. Porta, D. Barlocco, F. Meneghetti, B.M. Kwon, A. Asai, A. Gelain
Synthesis, structure-activity relationships and stereochemical investigations on new tricyclic pyridazinone derivatives as potential STAT3 inhibitors
2013 F. Meneghetti, D. Masciocchi, A. Gelain, F. Porta, A. Pedretti, G. Celentano, D. Barlocco, L. Legnani, L. Toma, B. Kwon, A. Asai, S. Villa
Synthesis, structure–activity relationships andstereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors
2013 D. Masciocchi, A. Gelain, F. Porta, F. Meneghetti, A. Pedretti, G. Celentano, D. Barlocco, L. Legnani, L. Toma, B.M. Kwon, A. Asai, S. Villa